When specialty providers think about longitudinal care—efforts to meet patients’ whole-health needs at each point in their care journey—their first thought is typically the resources required to pull it off. Ideally, longitudinal care examines not just the impact of a diagnosis on the individual, but also the risk for family members (e.g., “Should a cancer patient’s children undergo gene testing?”). It also seeks to answer: “What matters most to the patient?” Digging into these questions takes time and manpower.
Data is available in many forms from many sources, but it needs to be collected and organized in a way that turns it into actionable information. That is the challenge and the opportunity for healthcare IT and providers: to collaboratively assemble the right, easy-to-use systems for data collection and analysis while maximizing benefits and minimizing the headaches of manual processes.
Transitions of care went through a massive transformation during the COVID-19 pandemic. Ensuring patients moved safely between environments while remaining in-network became more complex with the needs and challenges of a mid-pandemic world, and avoiding readmissions and patient leakage became paramount. How has the industry risen to these growing changes, and what lies before us as the world strives to find a post-pandemic reality?
As new guidelines become available, a unified CVIS platform featuring structured reporting needs to integrate this information with no lag time to ensure the clinician has the latest data. Furthermore, by having access to the latest techniques, medical devices, protocols, and clinical recommendations, a cardiologist can offer the most accurate diagnoses and perform the most suitable procedures. Such innovations benefit the clinician and the clinic, but most importantly, they benefit the patient.
Ten bone-marrow transplant recipients will initially participate in the trial at the University of Colorado Anschutz Medical Campus, also known as CU Anschutz. The phased approach, through a series of studies, will scale the trial up over time to 100 participants, overseen by an institutional review board, and will include the use of predictive analytics, telemedicine, portable imaging, and supportive therapies such as antibiotics and hydration via IV.
The AHA voiced its opposition to establishing a permanent standard not aligned with evolving evidence-based guidance from the Centers for Disease Control and Prevention (CDC). The group suggested a permanent standard could create confusion, lower employee morale, and worsen healthcare staffing shortages.
Horine has been with the Houston-based accrediting organization (AO) since his former consulting company, TÜV Healthcare Specialists, was obtained by DNV in 2008, and has led the company for 10 years. Kelly Proctor, CHFM, CHSP, CHOP, DNV Healthcare’s director of operations, will take Horine’s place as president as of May 15, according to a company announcement.
In an announcement scheduled to be published in the Federal Register on May 2, CMS said that TJC made all the changes required of the agency but that “due to travel restrictions and the reprioritization of survey activities brought on by the 2019 Novel Coronavirus Disease (COVID-19) Public Health Emergency (PHE), CMS was unable to observe a hospital survey completed by TJC surveyors as part of the application review process, which is one component of the comparability evaluation. Therefore, we are providing TJC with a shorter period of approval.”
In 2020, there were more deaths from COVID-19 in the United States than any other country, and Americans had relatively high COVID-19 mortality rates. Before the pandemic, the United States had one of the lowest life expectancy rates among high-income countries.
On episode 52 of PSQH: The Podcast, Dr. Alexander Sah talks about the growth of the ambulatory surgery center market and how it’s improving the surgical process.